Maintenance / Service
PRODUCTS
-
Biotech companies progressing through clinical trials, planning an IPO, and undergoing rapid growth have a unique set of financial, contract, compliance, and reporting needs. We have designed an ERP solution, built on NetSuite, to address all of these needs. With over 50 implementations in the last two years alone, SuiteSuccess for Life Sciences is quickly becoming the defacto software standard for all successful biotechnology companies.
-
Whether you’re conducting an oncology trial, a neurology study, or imaging-based endpoint research, TrialKit’s flexible imaging capabilities can meet your needs.
-
Universal Column Protection
- Protects and extends UHPLC, HPLC and PREP column lifetime
- Virtually no change in chromatography
- Simple to use
-
PHCbi brand's 8.4 cu.ft. (238 L) compact microbiological heated and cooled incubator is designed to helps ensure highly accurate, reproducible environments that mimic real-world conditions. It offers precise control of temperature, a low humidity setting, and lighting protocols - making it ideal for microbiology testing and research, food and cosmetic shelf life testing, municipal wastewater testing, plant cell culturing, and more. It is completely programmable, allowing for direct numeric input with memory of operation, start dates and hours, clock mode and timer.
-
A set of 96-well plates prefilled with six different Capto™ hydrophobic interaction chromatography (HIC) resins for use in high-throughput process development (HTPD).
WHITE PAPERS AND CASE STUDIES
-
Calculating The ROI Of EAM/CMMS For Pharma Manufacturers And CDMOs
Learn how modern EAM and CMMS systems help pharma manufacturers reduce risk, improve compliance, and cut costs, as well as nine signs it’s time to move beyond outdated asset management practices.
-
Six Benefits Of Automating A Manual Quality Management System
Manual processes often lead to inefficiencies and increased errors. Discover the six benefits of automating a Quality Management System to improve accuracy and enhance compliance.
-
Recruitment To Screening: Bridging The Gap
Explore how providing tracked transportation for patients can streamline recruitment, improve site conversion rates, and deliver measurable ROI for clinical trials.
-
Rose Research Center Leans On Medrio To Simplify Workflows And Study Design
After experiencing paper processing issues, discover how a company transitioned to digital data collection by using Electronic Data Capture (EDC) and Electronic Patient Reported Outcomes (ePRO) solutions.
-
Enabling Seamless Study Management Across Clinical Trial Phases
Choosing the right eClinical solution can be difficult. Consider a platform’s various capabilities when deciding on a solution that performs and supports clinical trials at every study phase.
-
Greater Efficiency And Peace Of Mind With The KETOS SHIELD
In this case study, explore how a municipality automated its water quality testing to ensure compliance in real time.
-
Lean Six Sigma Methodology Drives Cost Savings: 2 Success Stories
Unlock significant lab efficiency and financial gains. See how focused optimization of workflows and asset management led to substantial cost savings and reclaimed six-figure value in consumables.
-
Working Smarter: Empowering Water Operators With Integrated Data
As water utilities face the challenges of sustainability, efficiency, and service quality, digital technology has become a necessity. The right tech can help deliver reliable service, optimize systems, and meet sustainability goals, but integrating the data streams these solutions generate can offer even greater gains – allowing utilities to move faster and achieve more powerful outcomes.
-
Advancing Cell And Gene Therapy Clinical Development In 2023
Examine considerations on bringing together the CMC and clinical teams early in the development process, promoting transparency and communication with regulators, and increasing patient access and diversity in clinical trials.
-
The Evolution Of SDV, SDR, And RBQM In Clinical Trial Data Quality
Explore the inefficiency of complete SDV and how the adoption of technologies like centralized monitoring, remote SDR, and targeted SDV can enhance data integrity and cost-effectiveness.
-
Orthogonal Methods To Understand And Define CQAs Of AAV Therapies
An essential part of AAV vector production is the characterization of potential CQAs. Learn about novel, robust, and orthogonal methods that can be used to assess identity, purity, and residuals.
-
GMP Manufacturing Cycle Time Reduction
Identifying process redundancies and enhancing visual management allows manufacturers to stabilize workflows. These data-driven improvements can decrease operational variability by nearly 50%.
NEWS
-
Flexxbotics Announces Robot Compatibility With Okuma Machine Tools2/2/2024
Flexxbotics, delivering workcell digitalization for robot-driven manufacturing, today announced robot machine tending connectivity compatible with the full range of Okuma CNC machines. With Flexxbotics next generation machining environments using robotics with Okuma equipment achieve higher yields, greater throughput and increased profit per part.
-
Swiss Re Selects mea Platform's GenAI Solution Across Global Reinsurance And Insurance Operations9/17/2024
mea announces today the selection of mea platform by Swiss Re and an expansion of the partnership between the two companies
-
Labcorp Presents New Research Demonstrating Clinical Impact Of Precision Diagnostics In Guiding Biomarker-Targeted Therapies For Patients With Epithelial Ovarian Cancer3/16/2024
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today presented the results from two studies at the 2024 SGO Annual Meeting on Women's Cancer.
-
NDWAC Sends Recommendations To EPA On Potential MDBP Rule Revisions1/2/2024
On December 14, the National Drinking Water Advisory Council (NDWAC) sent a letter to EPA Administrator Regan outlining the group’s recommendations for potential revisions to the Microbial and Disinfection Byproducts (MDBP) rules.
-
Sanofi And Orano Join Forces To Develop Next-Generation Radioligand Medicines10/17/2024
Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into an agreement to combine their expertise in the fight against rare cancers and further accelerate the development of next-generation radioligand medicines.